Hub gene identification and molecular subtype construction for Helicobacter pylori in gastric cancer via machine learning methods and NMF algorithm.

Helicobacter pylori (HP) is a gram-negative and spiral-shaped bacterium colonizing the human stomach and has been recognized as the risk factor of gastritis, peptic ulcer disease, and gastric cancer (GC). Moreover, it was recently identified as a class I carcinogen, which affects the occurrence and progression of GC via inducing various oncogenic pathways. Therefore, identifying the HP-related key genes is crucial for understanding the oncogenic mechanisms and improving the outcomes of GC patients. We retrieved the list of HP-related gene sets from the Molecular Signatures Database. Based on the HP-related genes, unsupervised non-negative matrix factorization (NMF) clustering method was conducted to stratify TCGA-STAD, GSE15459, GSE84433 samples into two clusters with distinct clinical outcomes and immune infiltration characterization. Subsequently, two machine learning (ML) strategies, including support vector machine-recursive feature elimination (SVM-RFE) and random forest (RF), were employed to determine twelve hub HP-related genes. Beyond that, receiver operating characteristic and Kaplan-Meier curves further confirmed the diagnostic value and prognostic significance of hub genes. Finally, expression of HP-related hub genes was tested by qRT-PCR array and immunohistochemical images. Additionally, functional pathway enrichment analysis indicated that these hub genes were implicated in the genesis and progression of GC by activating or inhibiting the classical cancer-associated pathways, such as epithelial-mesenchymal transition, cell cycle, apoptosis, RAS/MAPK, etc. In the present study, we constructed a novel HP-related tumor classification in different datasets, and screened out twelve hub genes via performing the ML algorithms, which may contribute to the molecular diagnosis and personalized therapy of GC.

[1]  P. Lin,et al.  EFNA3 is a prognostic biomarker for the overall survival of hepatocellular carcinoma patients. , 2022, Journal of Hepatology.

[2]  I. Ng,et al.  Ephrin-A3/EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma. , 2022, Journal of hepatology.

[3]  Yang Zhang,et al.  RNF114 Silencing Inhibits the Proliferation and Metastasis of Gastric Cancer , 2022, Journal of Cancer.

[4]  Fangzhou Song,et al.  LncRNA SNHG3 promotes gastric cancer cell proliferation and metastasis by regulating the miR-139-5p/MYB axis , 2021, Aging.

[5]  F. Cedrón,et al.  A review on machine learning approaches and trends in drug discovery , 2021, Computational and structural biotechnology journal.

[6]  Weimin Ma,et al.  Role of NRP1 in Bladder Cancer Pathogenesis and Progression , 2021, Frontiers in Oncology.

[7]  S. Lera,et al.  Uncovering feature interdependencies in high-noise environments with stepwise lookahead decision forests , 2021, Scientific Reports.

[8]  K. Matsuo,et al.  Effects of Helicobacter pylori eradication on gastric cancer incidence in the Japanese population: a systematic evidence review. , 2021, Japanese journal of clinical oncology.

[9]  Qianlan Yao,et al.  Impaired AGO2/miR-185-3p/NRP1 axis promotes colorectal cancer metastasis , 2021, Cell Death & Disease.

[10]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[11]  Hao Liu,et al.  FOXO3a-driven miRNA signatures suppresses VEGF-A/NRP1 signaling and breast cancer metastasis , 2020, Oncogene.

[12]  Frederick M. Howard,et al.  Machine Learning–Guided Adjuvant Treatment of Head and Neck Cancer , 2020, JAMA network open.

[13]  Xuancheng Lu,et al.  Sustained Exposure to Helicobacter pylori Lysate Inhibits Apoptosis and Autophagy of Gastric Epithelial Cells , 2020, Frontiers in Oncology.

[14]  Nayoung Kim,et al.  Promising aberrant DNA methylation marker to predict gastric cancer development in individuals with family history and long-term effects of H. pylori eradication on DNA methylation , 2020, Gastric Cancer.

[15]  J. Wei,et al.  Circ_0000515 drives the progression of hepatocellular carcinoma by regulating MAPK10. , 2020, European review for medical and pharmacological sciences.

[16]  R. Safaralizadeh,et al.  Helicobacter pylori‐related risk predictors of gastric cancer: The latest models, challenges, and future prospects , 2020, Cancer medicine.

[17]  Vanesa Segovia Bucheli,et al.  A comparative study of machine learning and deep learning algorithms to classify cancer types based on microarray gene expression data , 2020, PeerJ Comput. Sci..

[18]  P. Portincasa,et al.  Mechanisms of the Epithelial–Mesenchymal Transition and Tumor Microenvironment in Helicobacter pylori-Induced Gastric Cancer , 2020, Cells.

[19]  D. Metz,et al.  Risk Factors and Incidence of Gastric Cancer After Detection of Helicobacter pylori Infection: A Large Cohort Study. , 2020, Gastroenterology.

[20]  C. Adinortey,et al.  Helicobacter pylori Infection, Virulence Genes' Distribution and Accompanying Clinical Outcomes: The West Africa Situation , 2019, BioMed research international.

[21]  Jian Li,et al.  Immune cells within the tumor microenvironment: biological functions and roles in cancer immunotherapy. , 2019, Cancer letters.

[22]  Linyan Zhou,et al.  FAM60A, increased by Helicobacter pylori, promotes proliferation and suppresses apoptosis of gastric cancer cells by targeting the PI3K/AKT pathway. , 2019, Biochemical and biophysical research communications.

[23]  M. Poljak,et al.  Helicobacter pylori virulence genes , 2019, World journal of gastroenterology.

[24]  A. Vilanova,et al.  PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory receptors , 2019, Journal of Immunotherapy for Cancer.

[25]  V. Santosh,et al.  Expression pattern and prognostic significance of myosin light chain 9 (MYL9): a novel biomarker in glioblastoma , 2019, Journal of Clinical Pathology.

[26]  Xiaowu Xu,et al.  UHRF1 promotes aerobic glycolysis and proliferation via suppression of SIRT4 in pancreatic cancer. , 2019, Cancer letters.

[27]  Chen Ding,et al.  Quantum-Inspired Support Vector Machine , 2019, IEEE Transactions on Neural Networks and Learning Systems.

[28]  A. Rotte,et al.  Combination of CTLA-4 and PD-1 blockers for treatment of cancer , 2019, Journal of Experimental & Clinical Cancer Research.

[29]  Kun Wu,et al.  MicroRNA-140-5p inhibits cell proliferation, migration and promotes cell apoptosis in gastric cancer through the negative regulation of THY1-mediated Notch signaling , 2019, Bioscience reports.

[30]  Rochelle L. Tiedemann,et al.  Defining UHRF1 Domains that Support Maintenance of Human Colon Cancer DNA Methylation and Oncogenic Properties. , 2019, Cancer cell.

[31]  E. Jaffee,et al.  PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers. , 2019, JCI insight.

[32]  A. Jemal,et al.  Incidence Trends of Esophageal and Gastric Cancer Subtypes by Race, Ethnicity, and Age in the United States, 1997–2014 , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[33]  P. Malfertheiner,et al.  Helicobacter pylori Infection: New Facts in Clinical Management , 2018, Current Treatment Options in Gastroenterology.

[34]  Qiong Zhang,et al.  GSCALite: a web server for gene set cancer analysis , 2018, Bioinform..

[35]  Chang-qing Yang,et al.  UHRF1 mediates cell migration and invasion of gastric cancer , 2018, Bioscience reports.

[36]  A. Reyniès,et al.  Transcriptomic analysis of the tumor microenvironment to guide prognosis and immunotherapies , 2018, Cancer Immunology, Immunotherapy.

[37]  Feng Liu,et al.  Deep Learning and Its Applications in Biomedicine , 2018, Genom. Proteom. Bioinform..

[38]  C. Lindskog,et al.  The human protein atlas: A spatial map of the human proteome , 2018, Protein science : a publication of the Protein Society.

[39]  M. Ringnér,et al.  Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma , 2017, Nature Communications.

[40]  J. Meléndez-Zajgla,et al.  NRP1-positive lung cancer cells possess tumor-initiating properties , 2017, Oncology reports.

[41]  Ludmila V. Danilova,et al.  Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade , 2017, Science.

[42]  Jing Xu,et al.  Expression and prognostic significance of MYL9 in esophageal squamous cell carcinoma , 2017, PloS one.

[43]  Lihua Li,et al.  Dysregulated miR-27a-3p promotes nasopharyngeal carcinoma cell proliferation and migration by targeting Mapk10 , 2017, Oncology reports.

[44]  Huiqin Chen,et al.  Support Vector Machine Classification of Drunk Driving Behaviour , 2017, International journal of environmental research and public health.

[45]  D. Graham,et al.  Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis. , 2016, Gastroenterology.

[46]  Nicolai J. Birkbak,et al.  Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade , 2016, Science.

[47]  Fan Yang,et al.  An experimental study of the intrinsic stability of random forest variable importance measures , 2016, BMC Bioinformatics.

[48]  Rahul C. Deo,et al.  Machine Learning in Medicine , 2015, Mach. Learn. under Resour. Constraints Vol. 3.

[49]  F. Mégraud,et al.  Epidemiology and Diagnosis of Helicobacter pylori infection , 2015, Helicobacter.

[50]  Martin L. Miller,et al.  Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer , 2015, Science.

[51]  Helena Carreira,et al.  Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) , 2015, The Lancet.

[52]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[53]  I. Pinchuk,et al.  Immune evasion strategies used by Helicobacter pylori. , 2014, World journal of gastroenterology.

[54]  W. Park,et al.  The effect of Helicobacter pylori CagA on the HER-2 copy number and expression in gastric cancer. , 2014, Gene.

[55]  Z. Tulassay,et al.  Helicobacter pylori infection: new pathogenetic and clinical aspects. , 2014, World journal of gastroenterology.

[56]  Xavier Robin,et al.  pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.

[57]  Raquel Seruca,et al.  Helicobacter pylori infection generates genetic instability in gastric cells. , 2010, Biochimica et biophysica acta.

[58]  M. Piazuelo,et al.  Pathology of Gastric Intestinal Metaplasia: Clinical Implications , 2010, The American Journal of Gastroenterology.

[59]  Christian Fischer,et al.  FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? , 2008, Nature Reviews Cancer.

[60]  Mario Plebani,et al.  Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC). , 2006, Journal of the National Cancer Institute.

[61]  P. Malfertheiner,et al.  Helicobacter pylori Eradication Has the Potential to Prevent Gastric Cancer: A State-of-the-Art Critique , 2005, The American Journal of Gastroenterology.

[62]  J. Goedert,et al.  Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. , 2003, Gastroenterology.

[63]  E. Lesaffre,et al.  Dietary salt, nitrate and stomach cancer mortality in 24 countries. European Cancer Prevention (ECP) and the INTERSALT Cooperative Research Group. , 1996, International journal of epidemiology.

[64]  B. Marshall,et al.  UNIDENTIFIED CURVED BACILLI IN THE STOMACH OF PATIENTS WITH GASTRITIS AND PEPTIC ULCERATION , 1984, The Lancet.

[65]  Ash A. Alizadeh,et al.  Profiling Tumor Infiltrating Immune Cells with CIBERSORT. , 2018, Methods in molecular biology.